Catch up on the latest Molecule to Market episodes

20th June, 2023

If you didn’t already know, ramarketing is the proud sponsor of the leading life science outsourcing podcast Molecule to Market. Hosted by ramarketing’s Founder Raman Sehgal, he interviews an array of interesting individuals from the space covering topics such as;

  • Biopharma trends
  • M&A and PE sector activity
  • Entrepreneurship insights
  • Cell & Gene Therapy advancements
  • Industry events and networking

…to name just a few! Catch up on the latest episodes you might have missed.

Think you’ve got what it takes to be a guest?

We’re always on the lookout for new guests to come on the podcast, so if you’ve got insights that deserve to be heard, speak with your Account Manager about becoming a Molecule to Market guest, or submit a form via the website.

Ian Tzeng: Industry insights you cannot afford to miss

January welcomed L.E.K’s Managing Director, Ian Tzeng, to the podcast to talk all things trends. As a global strategy consulting firm, L.E.K. focuses on corporate strategy, marketing and sales, mergers and acquisitions, and operations – making Ian the expert when it comes to that helicopter view of the sector, identifying trends and challenges before they make their way to the surface. Ian’s episode discussed;

  • Insights, trends, and advice for CROs, CDMOs, and pharma services firms from one of the most prominent life science consultants
  • What he gained from his time studying at Harvard and the importance of genuine curiosity and a multi-disciplinary way of thinking
  • The complexity of modality and technology fragmentation, and the challenge of picking the right ones from a CDMO perspective
  • Why focusing on ‘conserved areas’ and ‘platform technologies’ could be a smart move when thinking about diversification and long term investments
  • The shift we are seeing from volume-based blockbuster drugs that deliver billions of pills to the masses, to targeted specialty drugs, to even more advanced therapies for micro-patient populations

Listen to Ian’s episode.

Raman Sehgal: Network like a pro

As we’re well underway with events season, we thought it was only right to highlight February’s best-performing episode where podcast host and ramarketing Founder, Raman Sehgal, gave his best advice on getting the most out of any event, networking dinner, or client meeting you may find yourself in. Whether you’re a seasoned pro or new to the world of networking, there’s always something to learn. Raman’s episode covered;

  • The importance of networking and how vital human interaction is to keep business going
  • Being your own brand and understanding your network is your net worth
  • Judging a book by its cover, and how that very thinking could cost you your next big deal
  • Adding value without pushing for the hard sell
  • How nurturing contacts and connections can reap rewards years down the line

Listen to the networking episode.

Mark Bamforth: Founding and selling three bio CDMOs – part 1 and part 2 

Mark joined Raman in March for an incredible 2-part episode, the first of its kind on Molecule to Market. With a reputation for being a titan in the industry, his episodes were some of the most downloaded in Q1 and sit in the top 5 episodes of all time on the podcast. Mark’s conversations covered;

  • Mark’s backstory from oil barrels to brewing, to a small biotech called… Genzyme
  • A baptism of fire of having to raise money for a self-funded CDMO carve-out after 22 years in the corporate world
  • How a merger strategy led to the sale of Gallus BioPharmaceuticals to Patheon
  • Entering the viral vector space, and the story of Brammer Bio from start-up to a $1.7bn exit to Thermo
  • How an unsolicited offer led to the unplanned sale of Arranta Bio to global CDMO Recipharm
  • Mark’s ability to spot trends of where the sector is going, and sometimes going against conventional wisdom
  • How he thinks about investment in early-stage and later-stage companies, as an investor
  • His take on the tougher, tighter funding environment and what it means for the market
  • Leadership lessons from 20+ years at Genzyme and three founder-to-exit successes

It’s safe to say, Mark’s episode is not one to miss – listen back to part 1 and part 2 now.

Derek Hennecke: The 30-year biotech and CDMO entrepreneur

In April, Raman spoke with Biotech & CDMO Entrepreneur, and Board Member, Derek Hennecke who imparted some serious wisdom on the M2M listeners. Throughout this conversation, they covered;

  • The behind-the-scenes story of acquiring, growing and selling Xcelience to Capsugel
  • Why Derek loves a carve-out with a clear differentiating capability and bags of growth potential
  • How he thinks about investments in both a VC and PE capacity, and how this has evolved
  • Why Derek is not seeing a slowdown across his portfolio companies…but why there could be a lag

Make sure you listen to Derek’s episode here.

Don’t wait to catch up with the episodes from Q2 so far!

If you aren’t already, make sure you’re subscribed to our mailing list to get weekly updates of new episodes and catch up with the latest episodes through the Molecule to Market website.